ALDX Aldeyra Therapeutics

NASDAQ

$0.92

Aldeyra Therapeutics (ALDX) Earnings News

Earnings press releases, previews and reviews for Aldeyra Therapeutics (ALDX), newest first.

Tuesday September 29, 2026 7:00 AM ET

Aldeyra Therapeutics Announces Intent to Submit Formal Dispute Resolution Request for Reproxalap to Treat Dry Eye Disease